Chemistry Department, Faculty of Science, Sohag University, Sohag, Egypt.
Department of Pharmacology and Toxicology, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA University), Giza, Egypt.
Arch Pharm (Weinheim). 2021 Apr;354(4):e2000241. doi: 10.1002/ardp.202000241. Epub 2020 Dec 18.
A new bidentate Schiff base ligand (ATBS [4-bromo-2-(thiazole-2-yliminomethyl)phenol]) was synthesized via the condensation reaction of 2-aminothiazole with 5-bromosalicylaldehyde in ethanol. The reaction of ATBS with transition metal salts of Cu(II), Co(II), Ni(II), and Mn(II) afforded the corresponding ATBS-M complexes. Results from physicochemical and spectral analyses, such as elemental analysis, infrared, UV-Vis spectroscopy, magnetic susceptibility, and molar conductance, revealed a nonelectrolytic nature with octahedral (O ) geometry and a metal/ligand ratio of 1:2 for Cu(II), Co(II), and Ni(II), but 1:1 for the Mn(II) complex. The density functional theory (DFT) calculations are correlated very well with the proposed structure and molecular geometry of the complexes as [M(ATBS) ] (M = Cu, Co, and Ni) and [Mn(ATBS)(H O) ]. Significantly, the prepared compounds showed strong inhibition activity for a wide spectrum of bacteria (Escherichia coli, Bacillus subtilis, and Staphylococcus aureus) and fungi (Candida albicans, Aspergillus flavus, and Trichophyton rubrum), with the ATBS-Ni complex being the most promising antibiotic agent. Molecular docking studies of the binding interaction between the title complexes with the bacterial protein receptor CYP51 revealed clear insights about the inhibition nature against the studied microorganisms, with the following order: ATBS-Cu > ATBS-Mn > ATBS-Ni > ATBS-Co for complex stability. Moreover, the cytotoxicity measurements of all prepared metal complexes against the colon carcinoma (HCT-116) and hepatocellular carcinoma (Hep-G2) cell lines showed exceptional anticancer efficacy of the complexes as compared with the free ATBS Schiff base ligand. Significantly, the results attested that ATBS-Cu is the most effective complex against HCT-116 cells, whereas ATBS-Mn has the highest cytotoxic efficiency against Hep-G2 cells. Furthermore, electronic spectra, viscosity measurements, and gel electrophoresis techniques were employed to probe the interaction of all prepared ATBS-metal complexes with calf thymus (CT)-DNA. Results confirmed that all complexes are strongly bound to CT-DNA via intercalation mode, with the ATBS-Co complex having the highest binding ability.
一种新型双齿希夫碱配体(ATBS[4-溴-2-(噻唑-2-亚基甲胺基)苯酚])通过在乙醇中缩合 2-氨基噻唑与 5-溴水杨醛合成。ATBS 与过渡金属盐 Cu(II)、Co(II)、Ni(II)和 Mn(II)的反应得到相应的 ATBS-M 配合物。物理化学和光谱分析的结果,如元素分析、红外、紫外可见光谱、磁化率和摩尔电导率,表明其具有非电解质性质,呈八面体(O)几何形状,Cu(II)、Co(II)和 Ni(II)的金属/配体比为 1:2,但 Mn(II)配合物为 1:1。密度泛函理论(DFT)计算与配合物的结构和分子几何形状非常相关,如[M(ATBS)](M=Cu、Co 和 Ni)和[Mn(ATBS)(H2O)]。值得注意的是,所制备的化合物对广泛的细菌(大肠杆菌、枯草芽孢杆菌和金黄色葡萄球菌)和真菌(白色念珠菌、黄曲霉和红色毛癣菌)表现出很强的抑制活性,其中 ATBS-Ni 配合物是最有前途的抗生素。标题配合物与细菌蛋白受体 CYP51 之间结合相互作用的分子对接研究清楚地揭示了对研究微生物的抑制性质,其顺序为:ATBS-Cu>ATBS-Mn>ATBS-Ni>ATBS-Co 用于配合物稳定性。此外,所有制备的金属配合物对结肠癌细胞(HCT-116)和肝癌细胞(Hep-G2)系的细胞毒性测量表明,与游离 ATBS 希夫碱配体相比,这些配合物具有出色的抗癌功效。值得注意的是,结果表明 ATBS-Cu 是对 HCT-116 细胞最有效的配合物,而 ATBS-Mn 对 Hep-G2 细胞的细胞毒性效率最高。此外,还采用电子光谱、粘度测量和凝胶电泳技术研究了所有制备的 ATBS-金属配合物与小牛胸腺(CT)-DNA 的相互作用。结果证实,所有配合物均通过嵌入模式与 CT-DNA 强烈结合,其中 ATBS-Co 配合物具有最强的结合能力。